Device Trial Radar · NCT04336618
Multi-Parametric MRI Assessment of the Liver in the Dallas-FortWorth Metroplex Population
Last checked: Nov 19, 2026Latest source record: Dec 22, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
67
Actual
Start
Aug 3, 2020
Primary completion
Sep 27, 2022
Study completion Sep 27, 2022
Sponsor
- Lead sponsor
- PerspectumNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 7, 2020
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To build a Registry of volunteers by inviting them to get a LiverMultiScan(LMS)and collecting their contact information to seek interest in participating in future studies.
Conditions
- Non-Alcoholic Fatty Liver Disease
Interventions
Liver MultiScanDevice
The LiverMultiscan is a quick 15 minute, contrast free, non-invasive MRI scan that provides 3 liver metrics
Primary outcomes
What the sponsor says the trial is designed to measure.
- To build a Registry of volunteers by inviting them to get a LiverMultiScan(LMS)and collecting their contact information to seek their interest in participating in future studiesTime frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Perspectum Inc.
Dallas, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.